Hi All, The stock looks undervalued now, I thought it would lift further with a dividend, $33M of net cash and double digit profit growth? Good return, low risk and growth? What's your view? Thanks
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%